T he term "molecular imaging" was coined only a few years ago, and there is still no real consensus as to what it means and encompasses. One of the better definitions of molecular imaging was by Luker and Piwnica-Worms [1] , who defined it as "the characterization and measurement of biologic processes in living animals, model systems, and humans at the cellular and molecular level by using remote imaging detectors." As the definition implies, an intrinsic or extrinsic signal-emitting probe that can be used to track a molecular event as well as a detection system that is sensitive enough to capture and quantify the emitted signal with sufficient signal to noise and contrast to noise in a spatially and temporally resolved manner is required. The importance and relevance of molecular imaging was heightened in 2003 because of several events: the celebration of the 50th anniversary of the discovery of the DNA double helix structure by Watson and Crick; completion of the sequencing of the human genome; awarding of the Nobel Prize in medicine and physiology to Prof. Paul Lauterbur and Sir Peter Mansfield, two pioneers in magnetic resonance imaging (MRI); and the announcement of the National Institutes of Health (NIH) roadmap, where molecular imaging features prominently together with the Molecular Library effort as an important initiative after the human genome project.
Why is molecular imaging receiving so much attention? Much of molecular biology research focuses on elucidating the functions of specific genes or gene products. Understanding how different gene products interact with each other in specific pathways and how these pathways respond to various modulations is important to further our knowledge of how individual cells carry out different functions. The complexity increases when one tries to sort out how different cells interact in a tissue and how different tissues interact in a whole organism in a coordinated manner. Working from a "bottom-up" approach has obviously given us much insight; however, it is increasingly clear that we need to observe molecular events in the in vivo environment so that in vitro observations can be validated. Molecular imaging offers the tools for a "top-down" approach in which molecular events can be observed in vivo in a whole organism, repeatedly, in a relatively noninvasive manner. Modulations of the molecular pathways can be performed and observations made without sacrificing the organism. With image-guided tissue procurement, cells with specific in-vivo characteristics can be extracted and analyzed using functional genomics, proteomics, and other techniques. With knowledge gained from the tissue analysis, new molecular-imaging probes can be designed so that eventually a cocktail of molecular probes, each emitting a different signal, can be used to study molecular pathways of interest under various modulating conditions. Obviously, this can be a highly iterative process with new experiments building on the knowledge gained from previous experiments. With this combined iterative "top-down" and "bottom-up" approach, hopefully new discoveries not possible with either approach alone can be made.
The review articles that are divided between this and the September issue offer a fairly good overview of the range of research that is ongoing in the field of molecular imaging. However, it is by no means all inclusive and encyclopedic. The goal of these special issues is to give the bioengineering community an idea of what molecular imaging is and to stimulate dialogue and future collaborations. Molecular imaging intrinsically requires a multidisciplinary approach with collaborations of physicists, engineers, chemists, biologists, and physicians. Let us work together to unravel "the complexity of life," which is the challenge and opportunity of this new century. His main research interest is in molecular imaging, which includes the devel-opment of novel-site and disease-specific drug delivery systems and integrating imaging with tissue analysis for studying system biology. He has served as principal or coinvestigator on multiple different grants with funding from institutional, industrial, and federal sources. He has eight issued and three pending patents on novel drug delivery systems and combining imaging with genomics and proteomics for developing new molecular targets and personalizing treatments. Dr. Li has won over ten different awards from four different professional organizations, four teacher of the year awards at three different institutions, and the NIH Director's Award in 2003. He has published close to 100 scientific and invited articles, five book chapters, and over 150 scientific abstracts. He is a reviewer of scientific manuscripts for five journals, the deputy editor of Academic Radiology, and guest editor for the Journal of Magnetic Resonance Imaging. He has lectured in numerous scientific meetings, academic institutions, educational courses, and workshops and was course director for two courses.
